APLS logo

Apellis Pharmaceuticals, Inc. (APLS) Free Cash Flow

Annual FCF:

-$88.27M+$507.24M(+85.18%)
December 31, 2024

Summary

  • As of today, APLS annual free cash flow is -$88.27 million, with the most recent change of +$507.24 million (+85.18%) on December 31, 2024.
  • During the last 3 years, APLS annual free cash flow has risen by +$475.96 million (+84.36%).
  • APLS annual free cash flow is now -2462.46% below its all-time high of -$3.44 million, reached on December 31, 2013.

Performance

APLS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

Quarterly FCF:

$4.40M+$57.81M(+108.23%)
June 30, 2025

Summary

  • As of today, APLS quarterly free cash flow is $4.40 million, with the most recent change of +$57.81 million (+108.23%) on June 30, 2025.
  • Over the past year, APLS quarterly free cash flow has increased by +$12.82 million (+152.15%).
  • APLS quarterly free cash flow is now -96.89% below its all-time high of $141.27 million, reached on December 31, 2020.

Performance

APLS Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

TTM FCF:

$4.41M+$12.82M(+152.48%)
June 30, 2025

Summary

  • As of today, APLS TTM free cash flow is $4.41 million, with the most recent change of +$12.82 million (+152.48%) on June 30, 2025.
  • Over the past year, APLS TTM free cash flow has increased by +$413.22 million (+101.08%).
  • APLS TTM free cash flow is now at all-time high.

Performance

APLS TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

APLS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+85.2%+152.2%+101.1%
3Y3 Years+84.4%+104.1%+100.9%
5Y5 Years+58.5%+104.6%+101.1%

APLS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+85.2%-87.1%+102.5%at high+100.7%
5Y5-Yearat high+85.2%-96.9%+102.5%at high+100.7%
All-TimeAll-Time-2462.5%+85.2%-96.9%+102.5%at high+100.7%

APLS Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.40M(+108.2%)
$4.41M(+152.5%)
Mar 2025
-
-$53.42M(-376.2%)
-$8.41M(+90.5%)
Dec 2024
-$88.27M(+85.2%)
$19.34M(-43.3%)
-$88.27M(+57.1%)
Sep 2024
-
$34.10M(+504.5%)
-$205.58M(+49.7%)
Jun 2024
-
-$8.43M(+93.7%)
-$408.81M(+25.8%)
Mar 2024
-
-$133.28M(-36.0%)
-$550.90M(+7.5%)
Dec 2023
-$595.51M(-15.6%)
-$97.97M(+42.1%)
-$595.51M(+6.8%)
Sep 2023
-
-$169.13M(-12.4%)
-$639.13M(-2.3%)
Jun 2023
-
-$150.53M(+15.4%)
-$624.61M(-7.4%)
Mar 2023
-
-$177.88M(-25.6%)
-$581.50M(-12.9%)
Dec 2022
-$515.27M(+8.7%)
-$141.59M(+8.4%)
-$515.27M(-6.0%)
Sep 2022
-
-$154.61M(-43.9%)
-$486.19M(+2.9%)
Jun 2022
-
-$107.42M(+3.8%)
-$500.56M(+4.1%)
Mar 2022
-
-$111.65M(+0.8%)
-$522.08M(+7.5%)
Dec 2021
-$564.23M(-240.1%)
-$112.52M(+33.4%)
-$564.23M(-81.7%)
Sep 2021
-
-$168.98M(-31.1%)
-$310.44M(-26.7%)
Jun 2021
-
-$128.94M(+16.2%)
-$245.03M(-16.2%)
Mar 2021
-
-$153.80M(-208.9%)
-$210.92M(-27.1%)
Dec 2020
-$165.91M
$141.27M(+236.4%)
-$165.91M(+57.4%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$103.56M(-9.2%)
-$389.41M(-14.8%)
Jun 2020
-
-$94.83M(+12.8%)
-$339.30M(-19.1%)
Mar 2020
-
-$108.78M(-32.3%)
-$284.84M(-33.8%)
Dec 2019
-$212.83M(-62.2%)
-$82.23M(-53.8%)
-$212.83M(-21.6%)
Sep 2019
-
-$53.46M(-32.4%)
-$175.08M(-13.1%)
Jun 2019
-
-$40.37M(-9.8%)
-$154.77M(-6.7%)
Mar 2019
-
-$36.77M(+17.3%)
-$145.09M(-10.5%)
Dec 2018
-$131.24M(-181.7%)
-$44.47M(-34.1%)
-$131.26M(-28.3%)
Sep 2018
-
-$33.15M(-8.0%)
-$102.32M(-27.4%)
Jun 2018
-
-$30.69M(-33.8%)
-$80.30M(-31.4%)
Mar 2018
-
-$22.94M(-47.7%)
-$61.10M(-31.1%)
Dec 2017
-$46.60M(-79.2%)
-$15.53M(-39.5%)
-$46.60M(-50.0%)
Sep 2017
-
-$11.14M(+3.1%)
-$31.06M(-55.9%)
Jun 2017
-
-$11.50M(-36.4%)
-$19.92M(-136.4%)
Mar 2017
-
-$8.43M
-$8.43M
Dec 2016
-$26.00M(-37.9%)
-
-
Dec 2015
-$18.86M(-89.2%)
-
-
Dec 2014
-$9.97M(-189.3%)
-
-
Dec 2013
-$3.44M
-
-

FAQ

  • What is Apellis Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is Apellis Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of APLS is -$88.27M

What is the all-time high annual free cash flow for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high annual free cash flow is -$3.44M

What is Apellis Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, APLS annual free cash flow has changed by +$507.24M (+85.18%)

What is Apellis Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of APLS is $4.40M

What is the all-time high quarterly free cash flow for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high quarterly free cash flow is $141.27M

What is Apellis Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, APLS quarterly free cash flow has changed by +$12.82M (+152.15%)

What is Apellis Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of APLS is $4.41M

What is the all-time high TTM free cash flow for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high TTM free cash flow is $4.41M

What is Apellis Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, APLS TTM free cash flow has changed by +$413.22M (+101.08%)
On this page